Table 2.

Domains and subdomains with no. mentions from participants

Domains	Subdomains	Domain explanations
Pharmacists as educators of patients and communities	Patient/medication Counseling: 15 General SUD: 3 Mental health: 6 Stigma: 4 Harm reduction: 8	Areas that interviewees identified as places where more education could be provided by pharmacists with regard to both patient and the community
Pharmacists as educators of health care providers	General SUD: 6 Harm reduction: 4	Areas that interviewees identified as places where more education could be provided to other health care providers by pharmacists
Pharmacists as advocates for individuals with SUD	MAT use: 6 Harm reduction: 9 Decreased cost: 1	Areas that pharmacists could advocate for systemic change as identified by interviewees
The need for increased pharmacist engagement owing to COVID-19 challenges for individuals with SUD	Reduced outreach: 7 Decreased mental health: 5 Increased overdoses: 4 Isolation: 7 Decreased accessibility: 6 Virtual learning curve: 3	Areas that interviewees identified related to the COVID-19 pandemic and its impact on SUD
The need for expanded pharmacy practice interventions	Telehealth services: 6 Harm reduction services: 5 Prevention services: 9 Mental health services: 5 School/Youth intervention (K-12): 5 Collaboration with SUD: 3	Areas where more pharmacy practice intervention and innovation is needed owing to COVID-19 as identified by interviewees
The need for pharmacist self-development	Addressing own stigma: 8 Role acknowledgment in SUD: 5 Consultation availability: 2	Steps that interviewees believe that pharmacists should take to become more actively involved in SUD treatment

Abbreviations used: SUD, substance use disorder; MAT, medication assisted treatment or medications for opioid use disorder; COVID-19, coronavirus disease 2019.